1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Brown-Forman reported first-quarter fiscal 2026 results for the period ended July 31, 2025, with net sales down 3% to $924 million (up 1% organic) and operating income down 7% to $260 million. Diluted earnings per share fell 13% to $0.36, and the company reaffirmed its full-year fiscal 2026 outlook for low-single-digit organic declines in net sales and operating income.
Net sales $924 million, down 3%; operating income $260 million, down 7%; diluted EPS $0.36, down 13%
Charges included $12 million in restructuring and other charges and a $19 million non-operating pension settlement charge
Full-year fiscal 2026 outlook reiterated: organic net sales and organic operating income each expected to decline in the low-single digit range
Board declared a quarterly dividend of $0.2265 per share, payable October 1, 2025, to holders of record on September 3, 2025
NAPCO Security Technologies reported fiscal 2025 results for the year ended June 30, 2025. Full-year net sales fell 3.8% to $181.6 million and net income fell 12.9% to $43.4 million, while fourth-quarter net sales rose 0.8% to $50.7 million but net income fell 14.1% to $11.6 million. The board also declared a $0.14 quarterly dividend.
Full-year diluted EPS was $1.19, down from $1.34 (down 11.2%); Q4 diluted EPS was $0.33, down from $0.36.
Full-year equipment sales were $95.3 million, down 16%; Q4 equipment sales were $28.3 million, down 5% year over year but up 27% from Q3.
Recurring service revenue rose 14% to $86.3 million for the year and 10% to $22.4 million in Q4, with a 91% gross margin for both periods.
Dividend of $0.14 per share is payable October 3, 2025, to shareholders of record on September 12, 2025.
Estée Lauder reported fiscal 2025 net sales of $14.33 billion, down 8% from the prior year, and a net loss of $3.15 per diluted share, compared with earnings of $1.08 per share a year earlier. Results were weighed down by $815 million of higher goodwill and intangible asset impairment charges and $362 million of restructuring and other charges, while adjusted diluted earnings per share fell 42% to $1.51. The company affirmed its fiscal 2026 outlook for a return to positive sales growth and improved operating profitability.
Net sales were $14,326 million, down from $15,608 million, and operating results swung to a loss of $785 million from income of $970 million.
Adjusted diluted net earnings per share were $1.51, compared with $2.59, and adjusted operating margin was 8.0%, compared with 10.2%.
Operating cash flow fell to $1.27 billion from $2.36 billion, and dividends paid were $618 million, down from $947 million.
The company affirmed its fiscal 2026 outlook; the filing states it includes estimates for fiscal 2026 full-year net sales and diluted net earnings per share.
Target reported second quarter 2025 net sales of $25.2 billion, down 0.9% from last year, and diluted EPS of $2.05 versus $2.57 a year earlier. Operating income fell 19.4% to $1.3 billion, and the company kept its fiscal 2025 guidance unchanged while its board named Michael Fiddelke as its next CEO.
Net sales were $25.2 billion, down 0.9%; comparable sales fell 1.9%, with comparable store sales down 3.2% and digital up 4.3%.
Diluted EPS was $2.05 compared with $2.57 in 2024, a 20.2% decline; operating income margin rate was 5.2% versus 6.4%.
Fiscal 2025 guidance was maintained: GAAP EPS of $8.00 to $10.00 and adjusted EPS of approximately $7.00 to $9.00.
The board unanimously appointed Michael Fiddelke as Target's next CEO; no stock was repurchased in the second quarter.
La-Z-Boy reported fiscal first-quarter 2026 results for the quarter ended July 26, 2025, with sales down 1% and GAAP diluted EPS down 28% from a year earlier. The company also guided to fiscal second-quarter sales of $510 million to $530 million and an adjusted operating margin of 4.5% to 6.0%, and said it is evaluating alternatives to address financial pressure from non-core parts of its business.
Sales were $492 million, down 1% from $495.5 million a year earlier; Retail written sales rose 5%, but Retail same-store written sales fell 4%.
GAAP diluted EPS was $0.44 versus $0.61; adjusted diluted EPS was $0.47 versus $0.62.
GAAP operating margin was 4.5% versus 6.5%; Joybird delivered sales fell 20% to $28 million.
Second-quarter outlook: sales of $510 million to $530 million and adjusted operating margin of 4.5% to 6.0%.
Ralliant reported second quarter 2025 revenue of $503 million, down 6% from a year earlier, and net earnings of $47.6 million, down from $64.8 million, following its separation from Fortive on June 28, 2025. The company also gave its first quarterly outlook, projecting third quarter revenue of $513 million to $527 million and adjusted EPS of $0.54 to $0.60, and authorized up to $200 million of share repurchases.
Q2 revenue $503 million, down 6% year over year; diluted EPS $0.42 versus $0.57 a year earlier
Test & Measurement operating loss of $14.3 million in the quarter; Sensors & Safety Systems revenue $310.8 million
Q3 2025 outlook: revenue $513 million to $527 million, adjusted EPS $0.54 to $0.60, adjusted EBITDA margin 18% to 20%
Board authorized up to $200 million of share repurchases on June 28, 2025; quarterly dividend of $0.05 per share declared August 6, 2025
AAON reported second-quarter 2025 net sales of $311.6 million, down 0.6% year over year, and GAAP diluted earnings per share of $0.19, down 69.4%. The company cut its full-year 2025 outlook, citing Longview facility inefficiencies and slower production at Tulsa tied to its ERP system rollout, which weighs on shareholders' earnings expectations.
Net sales fell 0.6% to $311.6 million; AAON Oklahoma sales fell 18.0%, while BASX sales rose 20.4% and AAON Coil Products sales rose 86.4%.
GAAP diluted EPS was $0.19, down 69.4%; non-GAAP adjusted diluted EPS was $0.22, down 64.5%.
Gross profit margin fell to 26.6% from 36.1%; adjusted EBITDA margin was 14.9% versus 26.1%.
Full-year 2025 outlook: low teens year-over-year sales growth and a 28%-29% gross profit margin; backlog rose 71.9% to $1.12 billion.
Roivant reported a loss from continuing operations of $273.9 million for the quarter ended June 30, 2025, compared with income of $31.6 million a year earlier, or $0.33 loss per share versus $0.01 income per share. Revenue fell to $2.2 million from $8.0 million, while research and development and general and administrative expenses rose, and share-based compensation increased sharply.
Revenue was $2.2 million versus $8.0 million in the prior-year quarter
Research and development expenses rose $32.4 million to $152.9 million; general and administrative expenses rose $34.1 million to $134.0 million
Share-based compensation in general and administrative expenses was $71.1 million versus $36.8 million
Cash, cash equivalents, restricted cash and marketable securities were $4.5 billion at June 30, 2025; a new $500 million buyback was approved in June 2025
Koppers reported second quarter 2025 sales of $504.8 million, down from $563.2 million a year earlier, and GAAP diluted EPS of $0.81 versus $1.25. The company cut its 2025 forecast, lowering its sales outlook to $1.9 billion to $2.0 billion from $2.0 billion to $2.2 billion and its adjusted EBITDA outlook to $250 million to $270 million, because it expects continued lower demand. Adjusted EPS rose to $1.48 from $1.36, but the lower sales and guidance cut weigh on the outlook for shareholders.
Q2 2025 net sales were $504.8 million, down 10.4% from $563.2 million; GAAP diluted EPS was $0.81 versus $1.25
Adjusted EPS was $1.48 versus $1.36 a year earlier; adjusted EBITDA was $77.1 million versus $77.5 million
2025 guidance revised: sales of $1.9 billion to $2.0 billion (previously $2.0 billion to $2.2 billion) and adjusted EBITDA of $250 million to $270 million
Adjusted EPS guidance is $4.00 to $4.60; operating cash flow projection of $150 million was maintained
Sylvamo reported second quarter 2025 net income of $15 million ($0.37 per diluted share), down from $27 million in the first quarter and $83 million a year earlier, with net sales of $794 million and adjusted EBITDA of $82 million. The company said results were in line with its outlook and guided third quarter adjusted EBITDA to $145 million to $165 million, citing lower planned maintenance outage expenses and improved volumes. For shareholders, the quarter was weaker, but the company expects a stronger second half.
Q2 net sales were $794 million, versus $821 million in Q1 2025 and $933 million in Q2 2024.
Net income was $15 million ($0.37 per diluted share), versus $27 million in Q1 2025 and $83 million in Q2 2024.
Third quarter adjusted EBITDA outlook is $145 million to $165 million, with planned maintenance outage expenses projected to fall by $66 million and no outages planned in the quarter.
$42 million remains on the $150 million share repurchase authorization from September 2023, and the board declared a $0.45 per share third quarter dividend.
Amphastar reported second-quarter 2025 results on August 7, 2025. Net revenues fell 4% to $174.4 million, and GAAP net income declined to $31.0 million, or $0.64 per diluted share, from $0.73 a year earlier. Growth in BAQSIMI sales was offset by lower glucagon and epinephrine sales, and the board increased its share buyback program by $50 million.
Net revenues were $174.4 million versus $182.4 million a year earlier, down 4%.
GAAP diluted EPS was $0.64 versus $0.73; adjusted non-GAAP diluted EPS was $0.85 versus $0.94.
BAQSIMI product revenues rose 51% to $46.7 million; epinephrine revenues fell 42% and glucagon fell 25%.
On August 5, 2025, the board authorized a $50 million increase to the share buyback program.
EOG Resources reported second quarter 2025 results that were lower than both the prior quarter and the same quarter of 2024. Diluted earnings per share were $2.46, down from $2.65 in the first quarter and $2.95 in the second quarter of 2024. The press release also includes third quarter and full year 2025 forecast and benchmark pricing information, but those figures are not in the filing text provided.
Total operating revenues and other were $5,478 million in Q2 2025, versus $5,669 million in Q1 2025 and $6,025 million in Q2 2024.
Net income was $1,345 million in Q2 2025, versus $1,463 million in Q1 2025 and $1,690 million in Q2 2024.
Adjusted diluted EPS (non-GAAP) was $2.32, versus $2.87 in Q1 2025; the company cited Encino acquisition-related costs of $18 million before tax as an adjustment.
Crude oil equivalent volumes rose to 1,090.4 MBoed in Q2 2025 from 1,062.1 MBoed in Q1 2025.
AMN Healthcare reported second-quarter 2025 revenue of $658 million, down 11% from a year earlier, and a net loss of $116.2 million, or $3.02 per diluted share, after $128 million in noncash goodwill and intangible asset impairment charges. Management said clients slowed decision-making amid an uncertain healthcare policy environment, and third-quarter revenue guidance of $610 million to $625 million is 9% to 11% below the prior year, so shareholders face both a sharp profit decline and a weaker near-term revenue outlook.
Q2 2025 revenue was $658 million, down 11% from $740.7 million in Q2 2024.
Net loss was $116.2 million, or $3.02 per diluted share, versus net income of $16.2 million, or $0.42 per diluted share, a year earlier.
Adjusted diluted EPS was $0.30, compared with $0.98 in the second quarter of 2024.
Third-quarter 2025 revenue is guided to $610 million to $625 million, 9% to 11% lower than the prior year.
Viatris reported second quarter 2025 results with total revenues of $3.6 billion, down 6% from a year earlier, and adjusted EPS of $0.62, down 10%. The company reaffirmed its 2025 guidance ranges and said it expects to land in the top half of the range for total revenues and adjusted EPS, which matters to shareholders because the company attributes the declines mainly to the Indore Impact.
Q2 2025 total revenues were $3.6 billion, down 6% reported and down 2% on a divestiture-adjusted operational basis versus Q2 2024.
U.S. GAAP net loss narrowed to $(5) million from $(326) million a year earlier; adjusted EPS was $0.62 versus $0.69.
The estimated Indore Impact reduced Q2 2025 total revenues by approximately $160 million.
2025 guidance reaffirmed: total revenues $13,500 million to $14,000 million and adjusted EPS $2.16 to $2.30; year-to-date capital returned exceeded $630 million, including $350 million in share repurchases.
Nexstar Media Group reported second-quarter 2025 results for the period ended June 30, 2025, with net revenue of $1.23 billion, down 3.2% from a year earlier, mainly due to lower political advertising. Net income fell 14.2% to $91 million and Adjusted EBITDA fell 6.0% to $389 million, while net cash from operating activities rose 40.3% to $247 million. Shareholders see lower revenue and profit, partly offset by higher operating cash flow and $106 million returned to shareholders in the quarter.
Net revenue was $1.23 billion, down $40 million or 3.2%; advertising revenue fell 9.0% to $475 million, with political advertising down $36 million.
Net income was $91 million, down 14.2%; Adjusted EBITDA was $389 million, down 6.0%, with margin at 31.7% versus 32.6%.
Net cash provided by operating activities rose 40.3% to $247 million; Adjusted Free Cash Flow was $101 million, up 31.2%.
In the quarter the company repaid $101 million of debt, paid $56 million in dividends and repurchased $50 million of stock; total debt was $6.4 billion as of June 30, 2025.
Evergy reported second quarter 2025 GAAP earnings of $171.3 million, or $0.74 per share, down from $207.0 million, or $0.90 per share, a year earlier. Adjusted EPS (non-GAAP) was $0.82, also below the prior-year $0.90, which the company attributed mainly to milder weather. The company reaffirmed its 2025 adjusted EPS guidance of $3.92 to $4.12, so shareholders see lower quarterly earnings but no change to the full-year outlook.
Q2 2025 GAAP EPS was $0.74 versus $0.90 in Q2 2024; adjusted EPS was $0.82 versus $0.90.
Cooling degree days fell 26% from the prior year due to milder weather, per the company.
2025 adjusted EPS guidance of $3.92 to $4.12 was reaffirmed, along with a 4% to 6% long-term annual growth target through 2029.
Quarterly dividend of $0.6675 per share is payable September 19, 2025, to holders of record as of August 22, 2025.
United Parks & Resorts reported second-quarter 2025 total revenue of $490.2 million, down 1.5% from a year earlier, and net income of $80.1 million, down 12.1%, with diluted EPS of $1.45 versus $1.46. The company cited worse weather as a headwind, though attendance rose 0.8%. The board also voted to recommend a new $500 million share buyback, subject to approval by non-Hill Path shareholders.
Q2 total revenue $490.2 million, down $7.4 million or 1.5%; net income $80.1 million, down 12.1%; diluted EPS $1.45 vs. $1.46
Q2 Adjusted EBITDA $206.3 million, down 5.4% from $218.2 million; attendance 6.2 million guests, up 0.8%
First six months: total revenue $777.2 million, down 2.2%; net income $64.0 million, down 20.0%
Board recommends a $500 million share buyback; the company expects a stockholder vote within 30 days
Prestige Consumer Healthcare reported first-quarter fiscal 2026 revenue of $249.5 million, down 6.6% from $267.1 million a year earlier, citing limited supply of Clear Eyes. It lowered its fiscal 2026 revenue and diluted EPS outlook and agreed to buy Pillar5 Pharma, its Clear Eyes supplier, for CAD 150 million in cash, subject to adjustments. The lower outlook reflects expected eye care supply shortfalls in the first half, and the acquisition is intended to secure supply, though closing depends on conditions and is expected in the third quarter of fiscal 2026.
Q1 fiscal 2026 revenue of $249.5 million, down 6.6% from $267.1 million; diluted EPS of $0.95 versus $0.98 a year earlier and $0.90 adjusted
Fiscal 2026 revenue outlook cut to $1,100 million to $1,115 million from $1,140 million to $1,155 million
Fiscal 2026 diluted EPS outlook cut to $4.50 to $4.58 from $4.70 to $4.82; free cash flow outlook of $245 million or more unchanged
Pillar5 Pharma acquisition for CAD 150 million in cash, expected to close in fiscal third quarter 2026 subject to conditions
MetLife reported second-quarter 2025 net income of $698 million, down 23% from a year earlier, and adjusted earnings of $1.4 billion, down 16%. The company said higher net derivative losses and lower adjusted earnings drove the net income decline, while premiums, fees and other revenues fell 6% to $12.7 billion. Shareholders also received approximately $900 million through share repurchases and dividends during the quarter.
Net income was $698 million, down 23%, or $1.03 per share, down 20%.
Adjusted earnings were $1.4 billion ($1,362 million), down 16%, or $2.02 per share, down 11%.
Adjusted premiums, fees and other revenues excluding pension risk transfers rose 5% to $12.4 billion.
Book value per share rose 7% to $35.79; the company returned approximately $900 million to shareholders.
Murphy Oil reported second quarter 2025 net income attributable to Murphy of $22.3 million, or $0.16 per diluted share, down from $127.7 million, or $0.83, a year earlier. Total revenues fell to $695.6 million from $802.8 million, and free cash flow was $17.8 million versus $174.4 million. Full-year capital expenditure guidance was reaffirmed at the midpoint of its range, and the company declared a $0.325 per share quarterly dividend.
Net income attributable to Murphy was $22.3 million ($0.16 diluted) versus $127.7 million ($0.83) in the second quarter of 2024.
Adjusted net income from continuing operations was $38.5 million ($0.27 per diluted share) versus $124.2 million ($0.81).
Production was 189,677 BOEPD, a sequential increase; full-year capital expenditure guidance was reaffirmed at the midpoint of the range.
Declared a quarterly dividend of $0.325 per share; closed a $23 million Eagle Ford Shale acquisition on July 1, 2025.
Tennant reported second-quarter 2025 net sales of $318.6 million, down 3.7% from a year earlier, and net income of $20.2 million, down 27.6%. Diluted EPS was $1.08 versus $1.45, and the company reaffirmed its 2025 guidance. The company attributed the decline mainly to lapping a $26 million backlog-reduction benefit in the prior-year quarter, while order rates rose 4.0%.
Net sales of $318.6 million, down 3.7%, with an organic decline of 4.5%
Adjusted EBITDA of $51.0 million versus $58.6 million a year earlier; margin 16.0%, down 170 basis points
Order rates increased 4.0% compared with the second quarter of 2024
2025 guidance reaffirmed: net sales of $1,210 million to $1,250 million and diluted EPS of $3.80 to $4.30
Veeco reported second quarter 2025 results for the period ended June 30, 2025, with revenue of $166.1 million, down from $175.9 million a year earlier. GAAP diluted EPS was $0.20 versus $0.25, and non-GAAP diluted EPS was $0.36 versus $0.42, so both revenue and profit declined year over year. The company also gave third quarter revenue guidance of $150 million to $170 million, with non-GAAP diluted EPS expected at $0.20 to $0.35.
Q2 2025 revenue was $166.1 million, compared with $175.9 million in Q2 2024, and above the $135 million to $165 million range given on May 7, 2025
GAAP net income was $11.7 million, or $0.20 per diluted share, versus $14.9 million, or $0.25, a year earlier
Non-GAAP net income was $21.5 million, or $0.36 per diluted share, versus $25.4 million, or $0.42, a year earlier
Q3 2025 guidance: revenue of $150 million to $170 million; GAAP diluted EPS of $0.04 to $0.22
Sonos reported third-quarter fiscal 2025 results, with revenue of $344.8 million, down from $397.1 million a year earlier, and a GAAP net loss of $3.4 million, compared with net income of $3.7 million in the prior-year quarter. The company said revenue was above the high end of its guidance range, but the filing does not state that range, and it did not provide new guidance in the release.
Revenue of $344.8 million vs. $397.1 million in the quarter ended June 29, 2024
GAAP net loss of $3.4 million, or $0.03 per diluted share, vs. net income of $3.7 million, or $0.03 per diluted share, a year earlier
Non-GAAP diluted EPS of $0.19 vs. $0.23 a year earlier; Adjusted EBITDA of $35.6 million vs. $48.9 million
Company will provide guidance on its earnings call on August 6, 2025, at 4:30 p.m. Eastern Time
Warrior Met Coal reported second quarter 2025 net income of $5.6 million, or $0.11 per diluted share, down from $70.7 million, or $1.35 per share, a year earlier, as total revenues fell to $297.5 million from $396.5 million amid lower steelmaking coal prices. The company also updated its full-year 2025 outlook and said first commercial sales from its Blue Creek mine came ahead of schedule.
Q2 2025 total revenues were $297.5 million, versus $396.5 million in Q2 2024; average net selling price fell 30.1% to $130.01 per short ton.
Q2 2025 Adjusted EBITDA was $53.6 million, versus $115.9 million in Q2 2024.
Updated 2025 guidance: coal sales of 8.8 to 9.5 million short tons and cash cost of sales of $110 to $120 per short ton.
Blue Creek longwall startup is now expected early in the first quarter of 2026.
Sunstone Hotel Investors reported second-quarter 2025 net income of $10.8 million, down from $26.1 million a year earlier, and lowered its full-year 2025 outlook. Revenue per available room (RevPAR) rose 2.2%, but the company cited weaker leisure demand in Maui, a slower ramp at Andaz Miami Beach, and subdued government business in Washington, DC, which it expects to pressure second-half performance.
Q2 2025 net income was $10.8 million versus $26.1 million; excluding an $8.8 million loss on the sale of the Hilton New Orleans St. Charles, it would have been $19.5 million.
Full-year 2025 net income guidance was cut to $14 million to $28 million from $24 million to $49 million adjusted prior guidance, a midpoint change of $15 million.
Full-year Adjusted EBITDAre guidance is now $226 million to $240 million, down from $233 million to $258 million adjusted prior guidance.
The company repurchased $100.0 million of stock year-to-date through August 5, 2025, at an average price of $8.83 per share, and declared a $0.09 quarterly common dividend payable October 15, 2025.
Lantheus reported second-quarter 2025 revenue of $378.0 million, down 4.1%, and adjusted diluted EPS of $1.57, down 12.8%, while GAAP diluted EPS rose 27.3% to $1.12. The company cut its full-year 2025 revenue and adjusted EPS guidance and said it faced increased competition in PSMA PET imaging, which hurt PYLARIFY sales; it also authorized a new $400 million share repurchase program.
Q2 2025 worldwide revenue was $378.0 million, down from $394.1 million; PYLARIFY sales fell 8.3% to $250.6 million.
Adjusted diluted EPS was $1.57, down from $1.80; GAAP diluted EPS was $1.12, up from $0.88.
FY 2025 revenue guidance was lowered to $1.475 billion-$1.51 billion from $1.550 billion-$1.585 billion; adjusted EPS guidance was lowered to $5.50-$5.70 from $6.60-$6.70.
The Board authorized repurchases of up to $400 million of common stock through December 31, 2027, replacing the program announced in November 2024.
International Seaways reported second quarter 2025 net income of $62 million, or $1.25 per diluted share, down from $145 million, or $2.91 per diluted share, a year earlier. Shipping revenues fell to $196 million from $257 million, and the company's board declared a combined $0.77 per share dividend, which shareholders would receive in September 2025.
Q2 2025 net income was $62 million, or $1.25 per diluted share, versus $145 million, or $2.91, in Q2 2024.
Shipping revenues were $196 million versus $257 million; adjusted EBITDA was $102 million versus $167 million.
On August 5, 2025, the board declared a combined $0.77 per share dividend, payable September 24, 2025 to holders of record on September 10, 2025.
Middleby reported second-quarter 2025 net sales of $977.9 million, down 1.4% from $991.5 million a year earlier, and GAAP diluted earnings per share of $1.99 versus $2.13. Management attributed the results to economic uncertainty in key end markets and issued third-quarter and full-year 2025 guidance, which projects revenue and adjusted EPS below the prior-year trend in the filing's figures. For shareholders, lower sales and earnings were partly offset by $322.7 million of share repurchases in the quarter.
Q2 2025 net sales were $977.9 million, down 1.4%; organic net sales fell 5.4%
GAAP net earnings were $106.0 million ($1.99 diluted EPS) versus $115.4 million ($2.13) a year earlier
Adjusted EBITDA was $200.2 million versus $216.4 million; the quarter included a $10 million tariff impact
Full-year 2025 guidance: total revenue of $3.81-3.87 billion, adjusted EBITDA of $770-800 million, adjusted EPS of $8.65-9.05
Kennametal reported fiscal fourth-quarter 2025 sales of $516 million, down 5% from $543 million, and diluted EPS of $0.28 versus $0.47 a year earlier. For fiscal 2025, diluted EPS was $1.20 versus $1.37, and the company expects fiscal 2026 adjusted EPS of $0.90 to $1.30, compared with fiscal 2025 adjusted EPS of $1.34, while it continues restructuring and footprint consolidation.
Q4 sales of $516 million, down 5% from $543 million; adjusted EPS of $0.34 versus $0.49
FY25 diluted EPS of $1.20 versus $1.37; adjusted EPS of $1.34 versus $1.50
FY26 outlook: sales of $1.95 to $2.05 billion and adjusted EPS of $0.90 to $1.30
Quarterly dividend of $0.20 per share declared, payable August 26, 2025
Louisiana-Pacific reported second-quarter 2025 results, with net sales down $60 million to $755 million and net income down $106 million to $54 million, or $0.77 per diluted share. The company reaffirmed its full-year 2025 siding guidance and said oriented strand board (OSB) prices are at multi-year lows, which is the main drag on results.
Q2 net sales fell $60 million to $755 million; siding sales rose $45 million (11%) to $460 million while OSB sales fell $101 million to $250 million
Q2 net income was $54 million ($0.77 per diluted share), down $106 million; Adjusted EBITDA was $142 million, down $86 million
Full-year 2025 consolidated Adjusted EBITDA guidance is about $405 million; third-quarter guidance is about $65 million
Quarterly cash dividend of $0.28 per share payable August 29, 2025, to holders of record as of August 15, 2025
Avista reported second-quarter 2025 net income of $14 million, or $0.17 per diluted share, down from $23 million, or $0.29, a year earlier. The company confirmed its 2025 EPS guidance of $2.52 to $2.72 but expects to land at the low end because of investment valuation losses, mainly in clean technology investments, while Avista Utilities is expected to finish toward the upper end of its own range.
Q2 2025 net income was $14 million and EPS was $0.17, versus $23 million and $0.29 in Q2 2024.
Year-to-date net income was $93 million and EPS was $1.15, versus $94 million and $1.20 a year earlier.
2025 consolidated EPS guidance of $2.52 to $2.72 was confirmed, with the company expecting the low end due to $0.15 of other-business losses in the first half.
Avista Utilities is expected to contribute toward the upper end of its $2.43 to $2.61 per-share range.
Interparfums reported second-quarter 2025 net sales of $334 million, down 2% from a year earlier, with operating income down 9% to $59 million and diluted EPS of $0.99 versus $1.14. Management said second-quarter results were affected by trade destocking and reaffirmed full-year 2025 guidance of $1.51 billion in net sales and $5.35 diluted EPS. The company also declared a regular quarterly dividend of $0.80 per share.
Q2 net sales $334 million (down 2%); gross margin rose 170 basis points to 66.2%
Q2 operating income $59 million (down 9%); net income attributable to Interparfums $32 million (down 13%)
First-half net sales $673 million (up 1%); first-half diluted EPS $2.32 vs $2.41
2025 guidance reaffirmed at $1.51 billion net sales and $5.35 diluted EPS; $0.80 dividend payable September 30, 2025
Vestis reported fiscal third-quarter 2025 revenue of $673.8 million, down $24.4 million or 3.5% from a year earlier, and a net loss of $0.7 million, or $(0.01) per diluted share, compared with net income of $5.0 million, or $0.04 per share, in the prior-year quarter. Adjusted EBITDA fell to $64.0 million from $86.9 million, and CEO Jim Barber said results were in line with the company's expectations. Shareholders face lower profit and a narrower margin for covenant compliance, with the Net Leverage Ratio at 4.50x against a 5.25x limit.
Revenue of $673.8 million, down $24.4 million (3.5%) year over year, driven by a $18.0 million decline in rental revenue
Net loss of $0.7 million, or $(0.01) per diluted share, versus net income of $5.0 million, or $0.04 per share, a year earlier
Adjusted EBITDA of $64.0 million versus $86.9 million in the prior-year quarter
Net Leverage Ratio of 4.50x; the credit agreement caps it at 5.25x for quarters ending before July 3, 2026
OUTFRONT Media reported second-quarter 2025 revenue of $460.2 million, down 3.6% from a year earlier, and net income attributable to the company of $19.5 million, down sharply from $176.8 million in the prior-year quarter, which included gains from the sale of its Canadian business. The company also declared a $0.30 per share quarterly dividend, and recorded $19.8 million of restructuring charges tied to its sales function reorganization.
Q2 2025 revenue was $460.2 million, down $17.1 million, or 3.6%, from $477.3 million; organic revenue was $460.2 million, down 0.2%.
Diluted net income per share was $0.10 versus $1.04 a year earlier; Adjusted OIBDA was $124.1 million, down 1.5%.
Restructuring charges were $19.8 million in the quarter, and the company expects SG&A expenses to decline for the rest of 2025 and the first half of 2026.
Board declared a $0.30 per share quarterly cash dividend, payable September 30, 2025, to holders of record on September 5, 2025.
Equitable Holdings reported a second-quarter 2025 net loss attributable to Holdings of $349 million, or $(1.21) per share, compared with net income of $428 million a year earlier. Non-GAAP operating earnings fell to $352 million, or $1.10 per share, from $495 million, or $1.43 per share, which the company attributed mainly to elevated mortality in its Individual Life block. Shareholders may weigh the July 31 closing of the Individual Life reinsurance deal with RGA, which the company says frees over $2 billion of capital, against the weaker quarterly earnings.
Net loss attributable to Holdings of $349 million, or $(1.21) per share, versus net income of $428 million in Q2 2024.
Non-GAAP operating earnings of $352 million, or $1.10 per share, versus $495 million, or $1.43 per share; $1.41 per share excluding notable items of $95 million.
Individual Life reinsurance transaction with RGA closed July 31, 2025; the company says it frees over $2 billion of capital and reduces mortality exposure by 75%.
The company returned $318 million to shareholders in Q2 and said it expects earnings per share growth to accelerate in the second half of 2025.
Aflac reported second-quarter 2025 net earnings of $599 million, or $1.11 per diluted share, down from $1.8 billion, or $3.10 per share, a year earlier. The drop reflects net investment losses of $421 million, while adjusted earnings fell 7.5% to $957 million, so shareholders face lower reported profit even as the company kept its dividend growing and repurchased $829 million of shares.
Total revenues were $4.2 billion, compared with $5.1 billion in the second quarter of 2024.
Adjusted earnings per diluted share decreased 2.7% to $1.78; net investment losses were $421 million.
The board declared a third-quarter dividend of $0.58 per share, payable September 2, 2025.
In the second quarter, Aflac repurchased 7.9 million shares for $829 million, with 30.9 million shares remaining authorized.
Teradata reported second-quarter 2025 total revenue of $408 million, down 6% from $436 million a year earlier, and GAAP diluted EPS of $0.09 versus $0.38. The company also set third-quarter and updated full-year 2025 outlook ranges, including a full-year total revenue range of -5% to -7% in constant currency, which shareholders will weigh against the lower current results.
Total revenue was $408 million versus $436 million, down 6% as reported; recurring revenue was $354 million versus $368 million
GAAP diluted EPS was $0.09 versus $0.38; non-GAAP diluted EPS was $0.47 versus $0.64
Third-quarter 2025 outlook: total revenue down 7% to 9% year over year in constant currency; non-GAAP diluted EPS of $0.51 to $0.55
Full-year 2025 outlook: total revenue down 5% to 7% in constant currency; non-GAAP diluted EPS of $2.17 to $2.25; public cloud ARR grew 17% to $634 million
Axcelis reported second-quarter 2025 revenue of $194.5 million, down from $256.5 million a year earlier, and GAAP diluted earnings per share of $0.98, down from $1.55. The company expects third-quarter revenue of about $200 million and GAAP diluted EPS of about $0.87, and it raised share repurchases to $45 million in the quarter, which shareholders may weigh against the lower year-over-year profit.
Q2 2025 revenue $194.5 million vs. $256.5 million in Q2 2024
Q2 2025 GAAP net income $31.4 million vs. $50.9 million; GAAP diluted EPS $0.98 vs. $1.55
Q3 2025 outlook: revenue of approximately $200 million, GAAP diluted EPS of approximately $0.87, non-GAAP EPS of approximately $1.00
Share repurchases increased to $45 million during the quarter
IPG Photonics reported second quarter 2025 results for the period ended June 30, 2025. Revenue fell 3% year over year to $250.7 million, and GAAP net income dropped 67% to $6.6 million, while the company guided third quarter 2025 revenue to $225 million to $255 million and adjusted EPS to $0.05 to $0.35.
Q2 2025 GAAP operating income was $0.1 million, down from $12.0 million in Q2 2024; GAAP diluted EPS was $0.16 versus $0.45.
Q2 2025 adjusted EPS was $0.30 versus $0.52 a year earlier, and adjusted EBITDA was $31.5 million versus $39.4 million.
Q3 2025 guidance: revenue of $225 million to $255 million, adjusted EPS of $0.05 to $0.35, and adjusted EBITDA of $22 million to $36 million.
During Q2 2025 the company spent $30 million on share repurchases and $15 million on capital expenditures.
Westlake reported a second-quarter 2025 net loss of $142 million, or $1.11 per diluted share, compared with net income of $313 million, or $2.40 per share, a year earlier. Net sales fell to $2.95 billion from $3.21 billion, and the results include $130 million of charges tied to closing the Pernis facility in The Netherlands and pausing a PVC unit in China. Excluding these items, the net loss was $12 million, or $0.09 per share, and the company expanded its cost-reduction target to an additional $200 million by 2026.
Net sales of $2,953 million in Q2 2025, down from $3,207 million in Q2 2024 but up from $2,846 million in Q1 2025.
Net loss of $142 million, or $1.11 per diluted share; excluding $130 million of identified items, net loss was $12 million, or $0.09 per share.
EBITDA excluding identified items was $340 million, compared with $744 million in Q2 2024 and $288 million in Q1 2025.
Cost-reduction target expanded to an additional $200 million of reductions by 2026, on top of a 2025 target of $150 million to $175 million.
AdaptHealth reported second quarter 2025 net revenue of $800.4 million, down 0.7% from $806.0 million, and net income attributable to the company of $14.7 million, down from $19.4 million. The company lowered its full-year 2025 Adjusted EBITDA guidance to $642 million to $682 million from $662 million to $702 million, which matters to shareholders because both headline profit and the outlook weakened.
Net revenue was $800.4 million versus $806.0 million a year earlier, a decrease of 0.7%.
Adjusted EBITDA was $155.5 million versus $165.3 million, a decrease of 5.9%.
Full-year 2025 Adjusted EBITDA guidance was lowered to $642 million to $682 million from $662 million to $702 million.
Full-year 2025 net revenue guidance was narrowed to $3.18 billion to $3.26 billion from $3.15 billion to $3.29 billion; free cash flow guidance of $170 million to $190 million was unchanged.
Archer-Daniels-Midland reported second-quarter 2025 results, with GAAP diluted EPS of $0.45 and adjusted EPS of $0.93, down 54% and 10% from the prior-year quarter. The company also narrowed its full-year 2025 adjusted EPS guidance to approximately $4.00 per share, based on first-half performance and expected margin benefits in the fourth quarter and beyond. For shareholders, lower earnings and a lower outlook point to weaker profitability, with management citing biofuel policy uncertainty and a challenging Ag Services and Oilseeds environment.
Q2 2025 net earnings attributable to ADM were $219 million, versus $486 million a year earlier; revenues were $21.2 billion, versus $22.2 billion.
Total segment operating profit was $830 million, down 10%; Ag Services and Oilseeds profit fell 17% to $379 million, and Crushing profit fell 75% to $33 million.
Full-year 2025 adjusted EPS guidance was tightened to approximately $4.00 per share.
Year-to-date operating cash flow was $4.0 billion, and the company said it remediated a previously identified material weakness related to segment disclosures.
Hamilton Lane reported fiscal first-quarter 2026 results for the quarter ended June 30, 2025, with total revenues of $176.0 million, down 11% from a year earlier, and diluted EPS of $1.28, down 13%. Fee Related Earnings rose 31% to $83.7 million, but lower incentive fees weighed on reported profit, and the company declared a $0.54 quarterly dividend.
Net income attributable to Hamilton Lane Incorporated was $53.7 million, down 9% year over year.
Incentive fees fell 26% to $42.3 million, while Fee Related Earnings increased 31% to $83.7 million.
Board declared a $0.54 quarterly dividend, payable October 6, 2025 to holders of record on September 19, 2025; the target full-year dividend of $2.16 is a 10% increase.
Marathon Petroleum reported second-quarter 2025 net income attributable to MPC of $1.2 billion, or $3.96 per diluted share, down from $1.5 billion, or $4.33 per share, a year earlier. Adjusted EBITDA fell to $3.3 billion from $3.4 billion, and the company returned about $1.0 billion to shareholders, including $692 million of share repurchases. MPLX also agreed to buy Northwind Midstream for $2.375 billion in cash, with closing expected in the third quarter of 2025.
Net income attributable to MPC was $1.2 billion, or $3.96 per diluted share, versus $1.5 billion, or $4.33 per share, in the second quarter of 2024.
Adjusted EBITDA was $3.3 billion versus $3.4 billion a year earlier; Refining & Marketing segment adjusted EBITDA was $1.9 billion versus $2.0 billion.
About $1.0 billion was returned to shareholders in the quarter, including $692 million of share repurchases; $6.0 billion remained under repurchase authorizations as of June 30, 2025.
MPLX agreed to acquire Northwind Midstream for $2.375 billion in cash, with closing expected in the third quarter of 2025, subject to customary conditions including regulatory clearance.
Cabot reported fiscal third-quarter 2025 results with diluted EPS of $1.86 and adjusted EPS of $1.90, both below the prior-year quarter, while net sales fell to $923 million from $1.016 billion. The company reaffirmed its fiscal 2025 adjusted EPS guidance of $7.15 to $7.50 but said that at current demand levels it expects to land in the middle to lower end of that range.
Diluted EPS was $1.86 versus $1.94 a year earlier; adjusted EPS was $1.90 versus $1.92, a 1% decrease
Net sales and other operating revenues were $923 million versus $1,016 million; net income attributable to Cabot was $101 million versus $109 million
Reinforcement Materials segment EBIT fell 6% to $128 million; Performance Chemicals segment EBIT rose 4% to $57 million
Fiscal 2025 adjusted EPS guidance of $7.15 to $7.50 was reaffirmed; management cited tariff uncertainty and weaker demand
Atlas Energy Solutions reported second-quarter 2025 revenue of $288.7 million, down 3.0% from the first quarter, and a net loss of $5.6 million, compared with net income of $1.2 million in the prior quarter. The company expects a modest decline in both consolidated revenue and Adjusted EBITDA in the third quarter, which weighs on the outlook for shareholders, though the quarterly dividend of $0.25 per share was maintained.
Q2 2025 revenue was $288.7 million, versus $297.6 million in Q1 2025 and $287.5 million in Q2 2024.
Net loss was $5.6 million, or $(0.04) per share, compared with net income of $1.2 million in Q1 2025.
Adjusted EBITDA was $70.5 million, down from $74.3 million in Q1 2025.
Third-quarter guidance calls for a modest decline in consolidated revenue and Adjusted EBITDA, with higher proppant volume offset by lower average prices and short-fall payments.
Boise Cascade reported second quarter 2025 net income of $62.0 million, or $1.64 per diluted share, down from $112.3 million, or $2.84 per share, a year earlier. Sales fell 3% to $1.74 billion, and adjusted EBITDA fell 34% to $119.0 million. Lower engineered wood and plywood prices and downtime for the Oakdale, Louisiana mill modernization weighed on the Wood Products segment, which lost most of its income.
Net income $62.0 million ($1.64 per diluted share) vs. $112.3 million ($2.84) in Q2 2024
Sales $1.74 billion, down 3% from $1.80 billion; Wood Products segment income fell 81% to $14.0 million
Board declared a quarterly dividend of $0.22 per share on July 31, 2025, payable September 17, 2025
Berkshire Hathaway reported second-quarter 2025 net earnings attributable to shareholders of $12.37 billion, down from $30.35 billion a year earlier, and first-half net earnings of $16.97 billion, down from $43.05 billion. Operating earnings, which exclude investment gains and losses, slipped to $11.16 billion from $11.60 billion, and the company recorded a $3.76 billion other-than-temporary impairment on its Kraft Heinz investment.
Q2 2025 net earnings were $12.37 billion, versus $30.35 billion in Q2 2024.
Q2 2025 operating earnings were $11.16 billion, versus $11.60 billion in Q2 2024.
Q2 2025 included a $3.76 billion other-than-temporary impairment of the Kraft Heinz investment.
Insurance float was approximately $174 billion at June 30, 2025, up $3 billion since year-end 2024.
Franklin Resources reported fiscal third-quarter results for the period ended June 30, 2025, furnished in an 8-K with a press release. GAAP net income attributable to the company fell 47% from a year earlier to $92.3 million, or $0.15 per diluted share, and operating revenues dropped 3% to $2,064.0 million. Shareholders are also weighing the $157.4 million spent on share repurchases and $9.3 billion in long-term net outflows.
Operating revenues were $2,064.0 million, down 3% from $2,122.9 million a year earlier and 2% from $2,111.4 million in the prior quarter.
Net income attributable to Franklin Resources was $92.3 million, or $0.15 per diluted share, versus $174.0 million, or $0.32, a year earlier.
Adjusted diluted EPS, a non-GAAP measure, was $0.49, compared with $0.60 a year earlier and $0.47 in the prior quarter.
Long-term net outflows were $9.3 billion; total AUM was $1,611.8 billion at June 30, 2025.
Arbor Realty Trust reported second quarter 2025 results on August 1, 2025, with net income attributable to common stockholders of $24.0 million, or $0.12 per diluted share, down from $47.4 million, or $0.25, a year earlier. Distributable earnings were $52.1 million, or $0.25 per diluted share, versus $91.6 million, or $0.45, in the second quarter of 2024. The company declared a $0.30 per share quarterly common dividend, payable August 29, 2025, to holders of record on August 15, 2025.
Net income attributable to common stockholders: $24.0 million ($0.12 per diluted share) vs. $47.4 million ($0.25) in Q2 2024
Distributable earnings: $52.1 million ($0.25 per diluted share) vs. $91.6 million ($0.45) in Q2 2024; excluding $10.5 million of realized losses from sales of two real estate owned properties, the company cites $0.30 per diluted share
Quarterly common dividend declared at $0.30 per share, payable August 29, 2025 to holders of record on August 15, 2025
In July 2025, the company issued $500.0 million of 7.875% senior unsecured notes due 2030 to repay $287.5 million of convertible senior notes
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.